Showing results (101-110 of 147) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancerP W Kantoff, S Halabi, D A Farmer, et al.Cancer Research|June 1, 1986
Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancerD F Hayes, M R Zalutsky, W Kaplan, et al.Journal of the National Cancer Institute|March 16, 2000
Association of angiogenesis in lymph node metastases with outcome of breast cancerA J Guidi, D A Berry, G Broadwater, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
Dose escalation of N,N',N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancerC L Shapiro, B J Dezube, O Tretyakov, et al.Cancer|December 1, 1993
Localization of tumor-associated glycoprotein DF3 in normal, inflammatory, and neoplastic lesions of the colonC W Andrews, J M Jessup, H Goldman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480D J George, S Halabi, T F Shepard, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 1, 1998
Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?T W Jacobs, K P Siziopikou, J E Prioleau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1985
Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinomaH Sekine, D F Hayes, T Ohno, et al.Journal of the National Cancer Institute|May 19, 1993
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodesC L Shapiro, R S Gelman, D F Hayes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivorsV Stearns, C Isaacs, J Rowland, et al.Pageof 15